{"organizations": ["VIVUS"], "uuid": "fcbc190a48f1ebaef5cc9efce2284996312fad56", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "us.rd.yahoo.com", "main_image": "", "site_section": "http://finance.yahoo.com/rss/headline?s=VVUS", "section_title": "Yahoo! Finance: VVUS News", "url": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125ppdjpl/*http://www.noodls.com/view/877A13BC144E17277A48E672AF384FF654C824AE", "country": "GB", "title": "VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call", "performance_score": 0, "site": "yahoo.com", "participants_count": 0, "title_full": "VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call", "spam_score": 0.0, "site_type": "news", "published": "2015-07-23T14:30:00.000+03:00", "replies_count": 0, "uuid": "fcbc190a48f1ebaef5cc9efce2284996312fad56"}, "author": "", "url": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125ppdjpl/*http://www.noodls.com/view/877A13BC144E17277A48E672AF384FF654C824AE", "ord_in_thread": 0, "title": "VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=69243&k=50618D32 \nToll-free: (877) 359-2916 \nInternational: (224) 357-2386 \nA webcast replay will be available on the VIVUS website for 30 days. \nVIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea and sexual health. For more information about the company, please visit www.vivus.com . \nCertain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as \"anticipate,\"\"believe,\"\"forecast,\"\"estimate,\"\"expect,\"\"intend,\"\"likely,\"\"may,\"\"plan,\"\"potential,\"\"predict,\"\"opportunity\" and \"should,\" among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2014 as filed on February 25, 2015 and as amended by the Form 10-K/A filed on April 30, 2015, and periodic reports   Commission. CONTACT: VIVUS, Inc.Dana B. Shinbaum (Corporate Development & Investor Relations) 650-934-5200 shinbaum@vivus.com The Trout GroupBrian Korb (Managing Director) 646-378-2923 bkorb@troutgroup.com Source: VIVUS, Inc.\nNews Provided by Acquire Media", "external_links": [], "published": "2015-07-23T14:30:00.000+03:00", "crawled": "2015-07-24T02:17:22.020+03:00", "highlightTitle": ""}